21,112.4
(211.55)
(1.01%)
09 Jul , 2026 | 04:14 PM
Open
20,910.7
Prev. Close
20,900.85
Market Cap.
₹0
Div Yield
0.46
PE
44.52
PB
44.52
20,889.95
21,307.05
Performance
One Week (%)
0.2
One Month (%)
4.77
One Year (%)
10.39
YTD (%)
17.48
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 26,770 | 26,890 | 26,200 | 24,860 |
Cipla Ltd | 1,441.3 | 1,454.8 | 1,426.4 | 9,47,375 |
Glaxosmithkline Pharmaceuticals Ltd | 2,440.4 | 2,460.8 | 2,397.3 | 71,685 |
J B Chemicals & Pharmaceuticals Ltd | 2,444.5 | 2,474 | 2,430.1 | 2,15,631 |
Pfizer Ltd | 4,590.1 | 4,637.6 | 4,518.1 | 40,992 |
Jubilant Pharmova Ltd | 969.2 | 988.4 | 964.1 | 1,02,229 |
Apollo Hospitals Enterprise Ltd | 8,845.5 | 8,920.5 | 8,756.5 | 5,71,832 |
Dr Reddys Laboratories Ltd | 1,269.5 | 1,349 | 1,261.1 | 84,10,883 |
Lupin Ltd | 2,503.3 | 2,522.7 | 2,455 | 5,70,462 |
Torrent Pharmaceuticals Ltd | 4,898.2 | 4,937.4 | 4,847 | 4,60,740 |
Ipca Laboratories Ltd | 1,770.4 | 1,797.2 | 1,762 | 96,723 |
Neuland Laboratories Ltd | 19,542 | 20,089 | 18,910 | 97,154 |
Sun Pharmaceutical Industries Ltd | 1,938.7 | 1,952 | 1,888.2 | 44,46,201 |
Caplin Point Laboratories Ltd | 2,621.4 | 2,638 | 2,550 | 1,19,270 |
Aurobindo Pharma Ltd | 1,587.4 | 1,602.8 | 1,550.1 | 8,03,529 |
Natco Pharma Ltd | 961.6 | 989.5 | 956.25 | 4,39,500 |
Wockhardt Ltd | 1,831.3 | 1,873.9 | 1,822 | 5,38,924 |
Granules India Ltd | 882.05 | 897.45 | 857.55 | 16,03,256 |
Ajanta Pharma Ltd | 3,307.6 | 3,385.1 | 3,263 | 56,018 |
Poly Medicure Ltd | 1,645.9 | 1,686 | 1,618 | 56,981 |
Gland Pharma Ltd | 2,469.5 | 2,522 | 2,462.2 | 3,59,295 |
Biocon Ltd | 403.55 | 409.6 | 394.85 | 55,90,149 |
Emcure Pharmaceuticals Ltd | 1,809.5 | 1,863.4 | 1,805 | 1,48,651 |
Alkem Laboratories Ltd | 5,648.5 | 5,695 | 5,602.5 | 39,730 |
Glenmark Pharmaceuticals Ltd | 2,267.2 | 2,293.8 | 2,227.1 | 4,27,091 |
Zydus Lifesciences Ltd | 1,159 | 1,171.3 | 1,144.9 | 9,86,789 |
Divis Laboratories Ltd | 6,813 | 6,945 | 6,740.5 | 3,56,468 |
Max Healthcare Institute Ltd | 1,101.3 | 1,123.7 | 1,083.3 | 25,25,140 |
Fortis Healthcare Ltd | 951.45 | 964 | 944.25 | 19,98,003 |
Syngene International Ltd | 415.4 | 426.05 | 409 | 13,45,366 |
Anthem Biosciences Ltd | 752 | 767.95 | 749.1 | 3,79,821 |
Global Health Ltd | 1,348.3 | 1,356 | 1,316.3 | 2,26,425 |
Krishna Institute of Medical Sciences Ltd | 813.75 | 831 | 801.75 | 5,36,192 |
Rainbow Childrens Medicare Ltd | 1,481.5 | 1,511.7 | 1,426.7 | 2,02,371 |
Mankind Pharma Ltd | 2,532 | 2,555.1 | 2,498.5 | 2,05,083 |
Dr Lal Pathlabs Ltd | 1,684.6 | 1,696.5 | 1,656.8 | 2,53,714 |
Indegene Ltd | 495.95 | 507.7 | 492.9 | 1,65,211 |
Narayana Hrudayalaya Ltd | 1,993.2 | 2,014 | 1,968 | 1,92,019 |
Laurus Labs Ltd | 1,507.4 | 1,524.6 | 1,460 | 20,35,031 |
ERIS Lifesciences Ltd | 1,430 | 1,439.9 | 1,404.2 | 85,753 |
Sai Life Sciences Ltd | 1,234.4 | 1,243 | 1,200 | 2,19,789 |
Aster DM Healthcare Ltd | 807.15 | 817.95 | 779 | 11,89,058 |
Concord Biotech Ltd | 1,305.4 | 1,311.2 | 1,250.1 | 1,21,847 |
Acutaas Chemicals Ltd | 3,458.8 | 3,488 | 3,368 | 4,86,255 |
Cohance Lifesciences Ltd | 440.15 | 448 | 425.1 | 4,54,022 |
Vijaya Diagnostic Centre Ltd | 1,377.8 | 1,395.8 | 1,324.8 | 2,49,185 |
Piramal Pharma Ltd | 171.99 | 175.95 | 166.25 | 78,59,690 |
Blue Jet Healthcare Ltd | 574.5 | 587 | 564.2 | 5,46,528 |
OneSource Specialty Pharma Ltd | 1,625.7 | 1,660 | 1,603 | 2,38,106 |
Indian benchmark indices rebounded on July 9, 2026, after the previous session's sharp sell-off. Nifty climbed 80.75 points while Sensex added 238.22 points, supported by strong gains in Realty, PSU Banks, and Consumer Durables. Stable crude oil prices, buying in heavyweight stocks, and Morgan Stanley's positive outlook on Indian equities boosted market sentiment.
9 Jul 2026|04:48 PM
Indian benchmark indices witnessed a broad-based sell-off on July 8, 2026, with the Nifty 50 and Sensex declining more than 2% as renewed US-Iran tensions, soaring crude oil prices, a weaker rupee, and rising market volatility dented investor sentiment. Banking and financial stocks led the decline, while most sectoral indices ended deep in the red amid growing geopolitical uncertainty.
8 Jul 2026|07:02 PM
Indian equities declined over 2% as escalating US-Iran tensions raised concerns over oil prices, inflation and global economic stability. Here's why geopolitical risks impacted Sensex and Nifty.
8 Jul 2026|03:53 PM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
